Pulling SEC filings + quote and writing the call…
HALO
HALOZYME THERAPEUTICS, INC.
Next earnings Aug 3, 2026 · consensus $1.85 EPS, $412M rev
Last earnings +3.6% on 2026-05-11
$68.55
▼ -0.03%$68.55▲ +27.13%
over 1Y
L $52.02EODHDH $81.23
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today-0.0%
1W-3.1%
1M-0.3%
3M+8.3%
YTD-2.5%
1Y+27.1%
Buy
Conviction
Horizon
Long (>12mo)
Street · 16 analysts
Buy
High-margin drug-delivery royalty engine growing revenue 38% at a reasonable 27x, but built on a levered, buyback-thinned balance sheet.
The read
Sources: SEC EDGAR (CIK 0001159036, latest 10-Q filed 2026-05-11) · EODHD · analysis by claude-code · as of 6/21/2026, 8:52:30 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.